PTX3 and type 2 diabetes mellitus: Within the T2DM cohort, we identified significant differences across the BMI categories with respect to PTX3, as determined by a one-way ANOVA test (p = 0.038), and TNF-α, assessed through the Kruskal–Wallis test (p = 0.028).